Generate Biomedicines, Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2024 | 2025 |
|---|---|---|
| – | -36.3% | |
| – | -42.5% | |
| – | -31.0% | |
| – | -43.7% | |
| – | -100.0% | |
| – | +0.0% | |
| – | -5.1% | |
| – | -10.2% | |
| – | -32.3% | |
| – | – | |
| – | – | |
| – | -60.7% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.